Israel Active

Israeli startup ForSight Robotics is developing a microsurgical robotic platform for eye surgery. The platform will exceed human surgical capabilities with unprecedented dexterity and maneuverability to within only a few microns.

Israel’s Belkin Laser (reported previously) is conducting a large-scale clinical study of its Eagle laser glaucoma treatment in Europe and Israel. Patients at more than 10 sites are testing the computer-guided device that uses healing lasers far less intrusively than currently approved devices.

Scientists at Ben Gurion University have confirmed the diagnosis of Alzheimer’s disease, epilepsy, traumatic brain injury and stroke from electroencephalogram (EEG) patterns. Analysis of changes in brain blood vessel pathology can provide fast diagnosis of those conditions.

Arab-Israeli Professor Ashraf Brik (see previously) of Israel’s Technion and his team have overcome a 60-year technical problem to synthesize plectasin, a peptide with promising antibiotic results against multi-resistant bacteria, and linaclotide, to treat irritable bowel syndrome.

IDC Herzliya researchers at Israel’s MIGAL laboratory, with Icelandic scientists, have identified that spirulina algae can reduce the cytokine storm that kills Covid-19 patients. The algae was supplied by Israel’s VAXA (Iceland based) who have EU funding to find natural cures for Covid-19.

Israel's Sheba Medical Center is partnering Israel’s Inspira Technologies in trials of its new respiratory treatment for Covid-19 patients suffering from acute breathing difficulties. The Augmented Respiration Treatment (ART) directly oxygenates blood while the patient remains conscious.

Israeli biotech Pepticom (reported previously) has raised $2.6 million to establish a company that can treat SARS-Cov-2 and its mutations. It will implement AI technology to design, discover and develop novel peptide molecules.

One of Israel’s Health Medical Organizations (HMOs) accidentally used a half-sized needle to apply the first Pfizer vaccine into 1,000 Israelis. But when 60% of them were tested three weeks later, they were all found to have high levels of antibodies. The US CDC was pleased to hear the outcome.

Israel’s Health Minister Yuli Edelstein has announced that 90% of Israelis over the age of 50 have been vaccinated or have recovered from COVID-19. 75% of them are eligible for a “Green Pass,” as they had their second vaccine over a week ago or have antibodies after virus recovery.

Israel’s Sheba Medical Center says it is the first hospital in the world to introduce patient-operated devices for hospitalized Covid-infected pregnant mothers to self-monitor their unborn babies. Israel’s HeraBEAT and PulseNmore devices are supported remotely by hospital medics.